Skip to main content

Find Clinical Trials

Home
Conditions
Tauopathies

Clinical trial condition

Tauopathies

Explore clinical trials studying Tauopathies. Study availability and eligibility vary by location and protocol.

3,028 public trials 536 recruiting studies

Refine in advanced search Browse all conditions

Tauopathies trial results

Completed

Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease

NCT01847586

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Centre for Addiction and Mental Health Toronto, Ontario, Canada

View Trial Details

Completed

Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters

NCT03408041

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: CHU Brugmann Brussels, Belgium

View Trial Details

Completed

Narcolepsy Protect Against Alzheimer's Disease?

NCT03378453

Conditions: Alzheimer Disease, Amyloid Pathology, Brain Diseases, +12 more
Locations: Montpellier University Hospital, Gui de Chauliac Montpellier, France

View Trial Details

Completed

Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms

NCT03349320

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD

NCT01920672

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

NCT00710684

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: GSK Investigational Site Litchfield Park, Arizona, United States

GSK Investigational Site Fresno, California, United States

GSK Investigational Site Rancho Mirage, California, United States

GSK Investigational Site San Francisco, California, United States

View all 102 locations

View Trial Details

Completed

CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease

NCT02021682

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations: Washington University in St. Louis St Louis, Missouri, United States

View Trial Details

Completed

Effectiveness of Flash Mediation Therapy

NCT02933177

Conditions: Alzheimer Disease, Behavior, Brain Diseases, +7 more
Locations: Hôpital des Charpennes Centre de Recherche Clinique "Vieillissement-Cerveau-Fragilité" Lyon, France

View Trial Details

Completed

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

NCT00843518

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Alzheimer Disease, +19 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Costa Mesa, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamden, Connecticut, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States

View all 17 locations

View Trial Details

Completed

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease

NCT00348309

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: GSK Investigational Site Litchfield Park, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

View all 249 locations

View Trial Details